Sign In

Login

Password

Forgot Password ? Sign Up

Tocilizumab (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tocilizumab" in Czech language version.

refsWebsite
Global rank Czech rank
16doi.org
2nd place
4th place
13worldcat.org
5th place
3rd place
8web.archive.org
1st place
1st place
8nih.gov
4th place
8th place
4fda.gov
447th place
753rd place
2gene.com
low place
low place
2roche.com
low place
low place
2tga.gov.au
3,984th place
low place
2wiley.com
222nd place
83rd place
2pharmac.govt.nz
low place
low place
2clinicaltrials.gov
5,225th place
2,661st place
1krankenpflege-journal.com
low place
low place
1europa.eu
68th place
38th place
1confex.com
6,094th place
9,806th place
1acrabstracts.org
low place
low place
1drugs.com
399th place
1,058th place
1pharmaceutical-technology.com
low place
low place
1mattioli1885journals.com
low place
low place
1sciencedirect.com
149th place
80th place
1bbc.co.uk
8th place
28th place
1archive.today
14th place
58th place
1adisonline.com
low place
low place
1wsj.com
79th place
324th place
1nps.org.au
low place
low place
1gazette.govt.nz
low place
low place
1pharmatimes.com
low place
low place
1reuters.com
49th place
92nd place
1ilfattoquotidiano.it
823rd place
low place
1ansa.it
493rd place
4,356th place
1ilmessaggero.it
1,738th place
low place
1swissinfo.ch
1,485th place
2,155th place
1yale.edu
565th place
738th place
1theguardian.com
12th place
39th place
1imperial.nhs.uk
low place
low place
1nice.org.uk
3,258th place
9,541st place
1medrxiv.org
low place
low place
1bbc.com
20th place
48th place
1scholar.google.com
1,697th place
4,140th place
1ajo.com
low place
low place
1mdpi.com
2,912th place
482nd place

acrabstracts.org

adisonline.com

  • Tocilizumab: A Review of its Use in the Management of Rheuma... : Dru…. archive.ph [online]. 2013-01-16 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2013-01-16. 

ajo.com

ansa.it

  • 3 patients get better on arthritis drug - English. ANSA.it [online]. 2020-03-13 [cit. 2021-12-06]. Dostupné online. (anglicky) 

archive.today

  • Tocilizumab: A Review of its Use in the Management of Rheuma... : Dru…. archive.ph [online]. 2013-01-16 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2013-01-16. 

bbc.co.uk

news.bbc.co.uk

  • Jab hope for rheumatoid arthritis. news.bbc.co.uk. 2008-10-27. Dostupné online [cit. 2021-12-06]. (anglicky) 

bbc.com

  • Arthritis drug tocilizumab cuts deaths from Covid. BBC News. 2021-02-11. Dostupné online [cit. 2021-12-06]. (anglicky) 

clinicaltrials.gov

  • NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID). Targeting Inflammation and Alloimmunity in Heart Transplant Recipients With Tocilizumab (RTB-004). [s.l.]: [s.n.] Dostupné online. Submitted: August 21, 2018. 
  • WANG, Guiqiang. Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019-A Multicenter, Randomized and Controlled Clinical Trial Study. [s.l.]: [s.n.] Dostupné online. Submitted: March 9, 2020. 

confex.com

acr.confex.com

  • Talk: LITHE: Tocilizumab Inhibits Radiographic Progression and Improves Physical Function in Rheumatoid Arthritis (RA) Patients (Pts) at 2 Yrs with Increasing Clinical Efficacy Over Time (2009 ACR/ARHP Annual Scientific Meeting). acr.confex.com [online]. [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2020-08-09. 

doi.org

dx.doi.org

  • GENOVESE, Mark C.; MCKAY, James D.; NASONOV, Evgeny L. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis & Rheumatism. 2008, roč. 58, čís. 10, s. 2968–2980. Dostupné online [cit. 2021-12-06]. ISSN 1529-0131. DOI 10.1002/art.23940. (anglicky) 
  • JONES, G; SEBBA, A; GU, J. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Annals of the Rheumatic Diseases. 2010-1, roč. 69, čís. 1, s. 88–96. PMID 19297346 PMCID: PMC3747519. Dostupné online [cit. 2021-12-06]. ISSN 0003-4967. DOI 10.1136/ard.2008.105197. PMID 19297346. 
  • KALLEN, Karl-Josef. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2002-11-11, roč. 1592, čís. The Molecular Biology of Cytokines, s. 323–343. Dostupné online [cit. 2021-12-06]. ISSN 0167-4889. DOI 10.1016/S0167-4889(02)00325-7. (anglicky) 
  • COWARD, Jermaine; KULBE, Hagen; CHAKRAVARTY, Probir. Interleukin-6 as a therapeutic target in human ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011-09-15, roč. 17, čís. 18, s. 6083–6096. PMID 21795409 PMCID: PMC3182554. Dostupné online [cit. 2021-12-06]. ISSN 1078-0432. DOI 10.1158/1078-0432.CCR-11-0945. PMID 21795409. 
  • MILAGRE, C.; GOPINATHAN, G.; EVERITT, G. Adaptive upregulation of EGFR limits attenuation of tumor growth by neutralizing IL-6 antibodies with implications for combined therapy in ovarian cancer. Cancer research. 2015-04-01, roč. 75, čís. 7, s. 1255–1264. PMID 25670170 PMCID: PMC4384986. Dostupné online [cit. 2021-12-06]. ISSN 0008-5472. DOI 10.1158/0008-5472.CAN-14-1801. PMID 25670170. 
  • HUNDT, Melanie A.; DENG, Yanhong; CIARLEGLIO, Maria M. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology. 2020, roč. 72, čís. 4, s. 1169–1176. Dostupné online [cit. 2021-12-06]. ISSN 1527-3350. DOI 10.1002/hep.31487. (anglicky) 
  • ALIJOTAS-REIG, Jaume; ESTEVE-VALVERDE, Enrique; BELIZNA, Cristina. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmunity Reviews. 2020-7, roč. 19, čís. 7, s. 102569. PMID 32376394 PMCID: PMC7252146. Dostupné online [cit. 2021-12-06]. ISSN 1568-9972. DOI 10.1016/j.autrev.2020.102569. PMID 32376394. 
  • STONE, John H.; FRIGAULT, Matthew J.; SERLING-BOYD, Naomi J. Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. The New England Journal of Medicine. 2020-10-21, s. NEJMoa2028836. PMID 33085857 PMCID: PMC7646626. Dostupné online [cit. 2021-12-06]. ISSN 0028-4793. DOI 10.1056/NEJMoa2028836. PMID 33085857. 
  • GROUP, RECOVERY Collaborative; HORBY, Peter W.; PESSOA-AMORIM, Guilherme. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. [s.l.]: [s.n.] Dostupné online. DOI 10.1101/2021.02.11.21249258v1. S. 2021.02.11.21249258. (anglicky) Type: article. 
  • KOMAI, Toshihiko; SHODA, Hirofumi; YAMAGUCHI, Kenichi. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report. Modern Rheumatology. 2016-03-03, roč. 26, čís. 2, s. 294–296. PMID 24313919. Dostupné online [cit. 2021-12-06]. ISSN 1439-7595. DOI 10.3109/14397595.2013.861333. PMID 24313919. 
  • AYZENBERG, Ilya; KLEITER, Ingo; SCHRÖDER, Alexandra. Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy. JAMA Neurology. 2013-03-01, roč. 70, čís. 3, s. 394–397. Dostupné online [cit. 2021-12-06]. ISSN 2168-6149. DOI 10.1001/jamaneurol.2013.1246. 
  • ARAKI, Manabu; ARANAMI, Toshimasa; MATSUOKA, Takako. Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab. Modern Rheumatology. 2013-7, roč. 23, čís. 4, s. 827–831. PMID 22782533 PMCID: PMC3713263. Dostupné online [cit. 2021-12-06]. ISSN 1439-7595. DOI 10.1007/s10165-012-0715-9. PMID 22782533. 
  • PEREZ-MOREIRAS, Jose V.; GOMEZ-REINO, Juan J.; MANEIRO, Jose R. Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial. American Journal of Ophthalmology. 2018-11-01, roč. 195, s. 181–190. PMID 30081019. Dostupné online [cit. 2021-12-06]. ISSN 0002-9394. DOI 10.1016/j.ajo.2018.07.038. PMID 30081019. (English) 
  • SÁNCHEZ-BILBAO, Lara; MARTÍNEZ-LÓPEZ, David; REVENGA, Marcelino. Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients. Journal of Clinical Medicine. 2020-09, roč. 9, čís. 9, s. 2816. Dostupné online [cit. 2021-12-06]. DOI 10.3390/jcm9092816. (anglicky) 

doi.org

drugs.com

  • FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis. Drugs.com [online]. [cit. 2021-12-06]. Dostupné online. (anglicky) 

europa.eu

ema.europa.eu

fda.gov

gazette.govt.nz

  • Consent to the Distribution of New Medicines - 2009-go6204 - New Zealand Gazette. gazette.govt.nz [online]. [cit. 2021-12-06]. Dostupné online. 

gene.com

  • Genentech: Press Releases | Genentech Gains FDA Approval for New Subcutaneous Formulation of Actemra® for use in Adult Patients Living with Moderately to Severely Active Rheumatoid Arthritis. web.archive.org [online]. 2017-09-08 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2017-09-08. 
  • Genentech: Press Releases. web.archive.org [online]. 2018-10-01 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2018-10-01. 

ilfattoquotidiano.it

  • Coronavirus, farmaco per curare l’artrite reumatoide efficace su due pazienti con polmonite severa da Covid 19. Il Fatto Quotidiano [online]. 2020-03-09 [cit. 2021-12-06]. Dostupné online. (italsky) 

ilmessaggero.it

  • Coronavirus, via libera dell'Aifa al farmaco anti-artrite efficace su 3 pazienti e a un antivirale: test in 5 centri. www.ilmessaggero.it [online]. 2020-03-13 [cit. 2021-12-06]. Dostupné online. (italsky) 

imperial.nhs.uk

  • Initial data shows arthritis drug is effective in treating sickest Covid-19 patients. www.imperial.nhs.uk [online]. [cit. 2021-12-06]. Dostupné online. (anglicky) 

krankenpflege-journal.com

  • Dr. med. Markus Harwart: Die Entwicklung von Tocilizumab - Medizinischer Fortschritt auf Basis einer erfolgreichen Kooperation von Chugai und Roche. web.archive.org [online]. 2018-10-15 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2018-10-15. 

mattioli1885journals.com

  • PARMENSIS, Acta Biomedica Atenei. Acta Biomedica Atenei Parmensis. mattioli1885journals.com [online]. [cit. 2021-12-06]. Dostupné online. (anglicky) 

mdpi.com

  • SÁNCHEZ-BILBAO, Lara; MARTÍNEZ-LÓPEZ, David; REVENGA, Marcelino. Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients. Journal of Clinical Medicine. 2020-09, roč. 9, čís. 9, s. 2816. Dostupné online [cit. 2021-12-06]. DOI 10.3390/jcm9092816. (anglicky) 

medrxiv.org

  • GROUP, RECOVERY Collaborative; HORBY, Peter W.; PESSOA-AMORIM, Guilherme. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. [s.l.]: [s.n.] Dostupné online. DOI 10.1101/2021.02.11.21249258v1. S. 2021.02.11.21249258. (anglicky) Type: article. 

nice.org.uk

  • Overview | COVID-19 rapid guideline: managing COVID-19 | Guidance | NICE. www.nice.org.uk [online]. [cit. 2021-12-06]. Dostupné online. 

nih.gov

ncbi.nlm.nih.gov

nps.org.au

  • Anakinra (Kineret) to be deleted from the PBS: NPS - Better choices, Better health. web.archive.org [online]. 2012-06-03 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2012-06-03. 

pharmac.govt.nz

pharmaceutical-technology.com

  • Hetero obtains DCGI approval to produce Roche's Covid-19 drug in India. www.pharmaceutical-technology.com [online]. [cit. 2021-12-06]. Dostupné online. (anglicky) 

pharmatimes.com

  • MCKEE, Selina. Roche links with UK gov for ground-breaking PAH trial. PharmaTimes [online]. 2016-01-06 [cit. 2021-12-06]. Dostupné online. (anglicky) 

reuters.com

  • China approves use of Roche drug in battle against coronavirus complications. Reuters. 2020-03-04. Dostupné online [cit. 2021-12-06]. (anglicky) 

roche.com

  • Roche - RoACTEMRA approved in Europe to treat patients suffering from Rheumatoid Arthritis. web.archive.org [online]. 2009-02-28 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2009-02-28. 
  • Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia. www.roche.com [online]. [cit. 2021-12-06]. Dostupné online. (anglicky) 

scholar.google.com

  • Google Scholar. scholar.google.com [online]. [cit. 2021-12-06]. Dostupné online. 

sciencedirect.com

  • KALLEN, Karl-Josef. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2002-11-11, roč. 1592, čís. The Molecular Biology of Cytokines, s. 323–343. Dostupné online [cit. 2021-12-06]. ISSN 0167-4889. DOI 10.1016/S0167-4889(02)00325-7. (anglicky) 

swissinfo.ch

  • LIMITED 2020, Hannah Kuchler in New York and Donato Paolo Mancini in London, Financial Times, Copyright The Financial Times. WHO and Roche launch trials of potential coronavirus treatments. SWI swissinfo.ch [online]. [cit. 2021-12-06]. Dostupné online. (anglicky) 

tga.gov.au

  • ADMINISTRATION, Australian Government Department of Health Therapeutic Goods. TGA Provisional Approval of Roche Products Pty Ltd COVID-19 treatment, tocilizumab (ACTEMRA). Therapeutic Goods Administration (TGA) [online]. 2021-12-01 [cit. 2021-12-06]. Dostupné online. (anglicky) 
  • Australian Drug Evaluation Committee - 263rd meeting recommendations. web.archive.org [online]. 2009-08-20 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2009-08-20. 

theguardian.com

  • Rheumatoid arthritis drug appears to help Covid patients in ICU. the Guardian [online]. 2020-11-19 [cit. 2021-12-06]. Dostupné online. (anglicky) 

web.archive.org

  • Dr. med. Markus Harwart: Die Entwicklung von Tocilizumab - Medizinischer Fortschritt auf Basis einer erfolgreichen Kooperation von Chugai und Roche. web.archive.org [online]. 2018-10-15 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2018-10-15. 
  • Genentech: Press Releases | Genentech Gains FDA Approval for New Subcutaneous Formulation of Actemra® for use in Adult Patients Living with Moderately to Severely Active Rheumatoid Arthritis. web.archive.org [online]. 2017-09-08 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2017-09-08. 
  • Roche - RoACTEMRA approved in Europe to treat patients suffering from Rheumatoid Arthritis. web.archive.org [online]. 2009-02-28 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2009-02-28. 
  • Talk: LITHE: Tocilizumab Inhibits Radiographic Progression and Improves Physical Function in Rheumatoid Arthritis (RA) Patients (Pts) at 2 Yrs with Increasing Clinical Efficacy Over Time (2009 ACR/ARHP Annual Scientific Meeting). acr.confex.com [online]. [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2020-08-09. 
  • Genentech: Press Releases. web.archive.org [online]. 2018-10-01 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2018-10-01. 
  • UPDATE: Roche: FDA Approves Actemra For Rheumatoid Arthritis - WSJ.com. web.archive.org [online]. 2010-01-14 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2010-01-14. 
  • Australian Drug Evaluation Committee - 263rd meeting recommendations. web.archive.org [online]. 2009-08-20 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2009-08-20. 
  • Anakinra (Kineret) to be deleted from the PBS: NPS - Better choices, Better health. web.archive.org [online]. 2012-06-03 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2012-06-03. 

wiley.com

onlinelibrary.wiley.com

  • GENOVESE, Mark C.; MCKAY, James D.; NASONOV, Evgeny L. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis & Rheumatism. 2008, roč. 58, čís. 10, s. 2968–2980. Dostupné online [cit. 2021-12-06]. ISSN 1529-0131. DOI 10.1002/art.23940. (anglicky) 
  • HUNDT, Melanie A.; DENG, Yanhong; CIARLEGLIO, Maria M. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network. Hepatology. 2020, roč. 72, čís. 4, s. 1169–1176. Dostupné online [cit. 2021-12-06]. ISSN 1527-3350. DOI 10.1002/hep.31487. (anglicky) 

worldcat.org

wsj.com

online.wsj.com

  • UPDATE: Roche: FDA Approves Actemra For Rheumatoid Arthritis - WSJ.com. web.archive.org [online]. 2010-01-14 [cit. 2021-12-06]. Dostupné v archivu pořízeném z originálu dne 2010-01-14. 

yale.edu

news.yale.edu

  • BELLI, Brita. Strong link found between abnormal liver tests and poor COVID-19 outcomes. YaleNews [online]. 2020-08-06 [cit. 2021-12-06]. Dostupné online. (anglicky)